Evaluation of dose and outcomes for pediatric vilazodone ingestions.
Christopher E GawHenry A SpillerJason L RussellThiphalak ChounthirathGary A SmithPublished in: Clinical toxicology (Philadelphia, Pa.) (2017)
Exposure to vilazodone poses a unique and potentially serious threat to children <6 years of age. Children in this age group who are exposed to vilazodone should be evaluated promptly in a clinical setting. Off-label use of vilazodone in children under 6 years should be discouraged until further research is conducted regarding its safety in this population.
Keyphrases